Medpace Holdings, Inc. (MEDP)
$612.05+1.55%Close
SELLBULL · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $17.1B
- Beta
- 1.18
- P/E (TTM)
- 34.67
- Short % float
- 7.10%
- Days to cover
- 5.8
- SI change
- -5.3%
- 1W
- +2.10%
- 1M
- +4.95%
- vs SPY 1W
- +0.94%
- vs SPY 1M
- +1.96%
Industry peers
FMP comparable companies · ranked by market cap
- 2268.HKWuXi XDC Cayman Inc$106.4B$84.00
- WUXIFWuXi AppTec Co., Ltd.$86.8B$29.10
- 300759.SZPharmaron Beijing Co., Ltd.$66.4B$44.97
- IQVSELLIQVIA Holdings Inc.$42.5BBEARQ 24$258.13+0.39%
- 603127.SSJoinn Laboratories(China)Co.,Ltd.$36.9B$49.30
- CRLBUYCharles River Laboratories International, Inc.$14.5BBULLQ 12$300.30+1.27%
- ICLRSELLICON Public Limited Company$12.6BRECOVERYQ 17$164.08-0.20%
- FTREBUYFortrea Holdings Inc.$2.0BBULLQ -1$20.56+2.31%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MEDP?
- LOPJLB’s latest quantitative signal on Medpace Holdings, Inc. (MEDP) is SELL in a BULL regime. Signals are updated daily.
- What market regime is MEDP in?
- Medpace Holdings, Inc. (MEDP) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Medpace Holdings, Inc. (MEDP) do?
- Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials thro…